Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Operating Income (2018 - 2025)

Historic Operating Income for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to -$7.6 million.

  • Bio's Operating Income rose 1933.8% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.5 million, marking a year-over-year increase of 677.73%. This contributed to the annual value of -$34.1 million for FY2024, which is 2259.78% up from last year.
  • As of Q3 2025, Bio's Operating Income stood at -$7.6 million, which was up 1933.8% from -$9.1 million recorded in Q2 2025.
  • Over the past 5 years, Bio's Operating Income peaked at -$4.8 million during Q1 2024, and registered a low of -$12.3 million during Q4 2023.
  • Over the past 5 years, Bio's median Operating Income value was -$9.4 million (recorded in 2022), while the average stood at -$9.1 million.
  • In the last 5 years, Bio's Operating Income surged by 5711.75% in 2024 and then plummeted by 11699.13% in 2025.
  • Quarter analysis of 5 years shows Bio's Operating Income stood at -$7.7 million in 2021, then dropped by 23.32% to -$9.4 million in 2022, then plummeted by 30.08% to -$12.3 million in 2023, then soared by 31.96% to -$8.4 million in 2024, then increased by 9.58% to -$7.6 million in 2025.
  • Its Operating Income stands at -$7.6 million for Q3 2025, versus -$9.1 million for Q2 2025 and -$10.5 million for Q1 2025.